Diabetic Retinopathy
📧 Sign up to get email alerts when something new happens for Diabetic Retinopathy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: CRYSTALSIGHT: ''Cohort 1.5" Clinical Investigation Study With OCCUTRACK and Tan Tock Seng Eye Clinic to Further Develop Remote Monitoring of Maculopathy at Home Using Artificial Intelligence for Eye Tracking
A completed clinical investigation called CRYSTALSIGHT Cohort 1.5 evaluates remote home monitoring of maculopathy using OCCUTRACK and AI eye…
-
CLINICAL_TRIALS research · 2025-12-30Clinical Trial Update: Wide Field OCTA in Ocular Diseases
Clinical trial update on a wide-field optical coherence tomography angiography (OCTA) study across several ocular diseases, sponsored by IRC…
-
CLINICAL_TRIALS research · 2025-12-24Clinical Trial Update: Comparing Single Versus Multiple Anti-VEGF Injections in Diabetic Patients Undergoing Cataract Surgery [Phase 4]
Phase 4 clinical trial comparing single versus multiple anti-VEGF injections in diabetic patients undergoing cataract surgery; currently not…
-
CLINICAL_TRIALS research · 2025-12-23Clinical Trial Update: Vascular Reparative Mechanism in Diabetes
Clinical trial update on a vascular reparative mechanism in diabetes, with focus on diabetic retinopathy; study status is active but not rec…
-
CLINICAL_TRIALS trial_result · 2025-12-19Clinical Trial Update: Impact of Diabetes Mellitus on Retinal Microvasculature in Patients Without Clinical Retinopathy Using Optical Coherence Tomography Angiography
A completed clinical trial from Sohag University studied how diabetes mellitus affects the retinal microvasculature in patients without clin…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-12-18Clinical Trial Update: Retinal Clinical Assessment With AI-derived Quantitative Information
This clinical trial update describes an AI-derived retinal imaging assessment intended to provide quantitative information across several re…
-
EMA approval · 2025-12-17EMA Authorised: Lucentis (ranibizumab) — Novartis Europharm Limited
EMA authorised Lucentis (ranibizumab) for multiple ophthalmic indications including wet age-related macular degeneration, macular edema, dia…
-
CLINICAL_TRIALS trial_result · 2025-12-12Clinical Trial Update: Study to Evaluate Clinical Efficacy and Safety of Nuvastatic™ - C5OSEW5050ESA in Diabetic Retinopathy. [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating the efficacy and safety of Nuvastatic for diabetic retinopathy has completed.
-
EMA approval · 2025-12-10EMA Authorised: Eydenzelt (aflibercept) — Celltrion Healthcare Hungary Kft.
EMA authorised Eydenzelt (aflibercept) from Celltrion Healthcare Hungary Kft. for multiple ocular conditions including wet age-related macul…
-
CLINICAL_TRIALS research · 2025-12-09Clinical Trial Update: Assessment of AI Program 'DRISTi' as a Screening Tool
A clinical trial update indicates Artelus AI's DRISTi program is being evaluated as a screening tool for diabetic retinopathy and the study …
-
CLINICAL_TRIALS trial_result · 2025-12-05Clinical Trial Update: Characterization of Retinal Disease Progression in Eyes With Non Proliferative Diabetic Retinopathy in Diabetes Type 2 Using Non-invasive Procedures (CHART)
This completed clinical trial update characterizes the progression of non-proliferative diabetic retinopathy in adults with type 2 diabetes …
-
CLINICAL_TRIALS trial_result · 2025-12-04Clinical Trial Update: Effect of OMEGA3 Supplementation in Diabetic Retinopathy [NA]
A completed clinical trial investigating omega-3 fatty acid supplementation for diabetic retinopathy.
-
CLINICAL_TRIALS trial_result · 2025-12-02Clinical Trial Update: The Efficacy of Intravitreal Aflibercept Injection in Improvement of Retinal Nonperfusion in Diabetic Retinopathy [Phase 2]
Phase 2 clinical trial evaluating intravitreal aflibercept for improving retinal nonperfusion in diabetic retinopathy has completed. The upd…
-
CLINICAL_TRIALS research · 2025-12-01Clinical Trial Update: Effect of Omega-3 Fatty Acids on Eye Blood Vessels in Type 1 Diabetes [NA]
A clinical trial is evaluating whether omega-3 fatty acids affect eye blood vessels in people with type 1 diabetes. The study focuses on dia…
-
CLINICAL_TRIALS trial_result · 2025-11-25Clinical Trial Update: A Multicenter, Randomized Study in Participants With Diabetic Retinopathy Without Center-involved Diabetic Macular Edema To Evaluate the Efficacy, Safety, and Pharmacokinetics of Ranibizumab Delivered Via the Port Delivery System Relative to the Comparator Arm [Phase 3]
Phase 3 randomized trial evaluating the efficacy, safety, and pharmacokinetics of ranibizumab delivered via the Port Delivery System in diab…
-
CLINICAL_TRIALS trial_result · 2025-11-25Clinical Trial Update: AI for the Detection of Retinal Disease and Glaucoma in Patients With Diabetes Mellitus in Primary Care [NA]
A completed clinical trial evaluating AI-based detection of retinal disease and glaucoma in adults with diabetes within primary care.
-
CLINICAL_TRIALS research · 2025-11-25Clinical Trial Update: High-throughput Large-model-based AI-assisted Diagnosis Using OCT
A clinical trial update for a high-throughput AI system using OCT for retinal disease diagnosis; the study is not yet recruiting.
-
EMA approval · 2025-11-21EMA Authorised: Eiyzey (aflibercept) — Zaklady FarmaFarmaceutyczne Polpharma S.Aceutyczne Polpharma S.A.
The EMA authorised Eiyzey (aflibercept) from Zaklady Farmaceutyczne Polpharma S.A. for multiple retinal diseases, including wet age-related …
-
CLINICAL_TRIALS research · 2025-11-21Clinical Trial Update: Epiretinal Membrane in Patients With DR.
A clinical trial investigating epiretinal membrane in patients with diabetic retinopathy is listed as not yet recruiting.
-
CLINICAL_TRIALS research · 2025-11-19Clinical Trial Update: Artificial Intelligence for Diagnosing Diabetic Retinopathy in Primary Care [NA]
This Clinical Trial Update describes a study evaluating an artificial intelligence tool to diagnose diabetic retinopathy in primary care, cu…
-
CLINICAL_TRIALS research · 2025-11-19Clinical Trial Update: Efficacy and Safety of Ginkgo Biloba Extract EGb761® in Patients With Diabetic Retinopathy [Phase 2]
A Phase 2 clinical trial is evaluating the efficacy and safety of EGb761, a Ginkgo biloba extract, in patients with non-proliferative diabet…
-
CLINICAL_TRIALS research · 2025-11-19Clinical Trial Update: Artificial Intelligence-Aided Screening for Patients With Diabetic Retinopathy and Age-related Macular Degeneration in Family Medicine and Geriatric Medicine Outpatient Clinics [NA]
A clinical trial sponsored by National Taiwan University Hospital is testing AI-assisted screening for diabetic retinopathy and age-related …
-
CLINICAL_TRIALS research · 2025-11-18Clinical Trial Update: Effect of Levosulpiride on Retinal Alterations in Patients With Diabetic Retinopathy and Diabetic Macular Edema [Phase 2]
Phase 2 clinical trial evaluating the effect of levosulpiride on retinal alterations in patients with diabetic retinopathy and diabetic macu…
-
CLINICAL_TRIALS research · 2025-11-18Clinical Trial Update: Single Session vs Multiple-Session Panretinal Photocoagulation for Treatment of Proliferative Diabetic Retinopathy [NA]
Clinical trial evaluating single-session versus multiple-session panretinal photocoagulation for proliferative diabetic retinopathy, with re…
-
EMA approval · 2025-11-14EMA Authorised: Ranivisio (ranibizumab) — Midas Pharma GmbH
The EMA authorised Ranivisio (ranibizumab) for ocular indications including wet age-related macular degeneration, macular edema, and diabeti…